Tuberculosis treatment failure and drug resistance—same strain or reinfection?
Authors:
- Pamela SonnenbergPSPamela Sonnenberg
- Jill MurrayJMJill Murray
- Stuart ShearerSSStuart Shearer
- Judith R. GlynnJGJudith R. Glynn
- Bupe KambashiBKBupe Kambashi
- Peter Godfrey-FaussettPGPeter Godfrey-Faussett
- 1 November 2000
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 94 (6) , 603-607
Abstract
Tuberculosis patients may have Mycobacterium tuberculosis in their sputum at the end of treatment, and may show new drug resistance, due to either inadequate treatment of the original episode or reinfection with a new strain during therapy. In a cohort study of mineworkers with tuberculosis in South Africa, 57 of 438 patients had positive sputum cultures 6 months after recruitment in 1995. Of the 31 patients who initially had fully sensitive strains, 3 developed multidrug resistance (MDR) and 3 single-drug resistance (SDR). Of the 6 who started with SDR, 3 became MDR. HIV infection was not associated with drug resistance at enrollment or 6 months later. We compared pairs of DNA fingerprints from isolates of M. tuberculosis at recruitment and 6 months later in the 48 patients for whom we had both available. In 45, the pairs were identical. In 1 patient, although both isolates were fully sensitive, the later fingerprint had 1 less band (transposition). In 2 pairs, the fingerprint patterns were completely different: one seemed to be the result of laboratory error and the other was a true reinfection with an MDR strain. Despite a high risk of infection, with a moderate proportion of background drug-resistant strains (11% SDR, 6% MDR), reinfection is not a common cause of treatment failure or drug resistance at 6 months.Keywords
This publication has 28 references indexed in Scilit:
- Analysis of Rate of Change of IS6110RFLP Patterns ofMycobacterium tuberculosisBased on Serial Patient IsolatesThe Journal of Infectious Diseases, 1999
- First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisonsThe Lancet, 1999
- Resurgence of tuberculosis and the impact of HIV infectionBritish Medical Bulletin, 1998
- The Incidence of False-Positive Cultures for Mycobacterium TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Retrospective Detection of Laboratory Cross-Contamination of Mycobacterium tuberculosis Cultures with Use of DNA Fingerprint AnalysisClinical Infectious Diseases, 1997
- An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991–1993AIDS, 1996
- Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family1996
- Transmission of Multidrug-Resistant Tuberculosis in a Large Urban SettingAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'IvoireThe Lancet, 1995
- An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1992